Christina Ackermann - 05 May 2022 Form 3 Insider Report for Bausch & Lomb Corp (BLCO)

Role
Officer
Signature
/s/ Debra E. Levin, attorney-in-fact
Issuer symbol
BLCO
Transactions as of
05 May 2022
Net transactions value
$0
Form type
3
Filing time
05 May 2022, 18:33:37 UTC
Previous filing
11 Mar 2022
Next filing
03 Jun 2022

No securities are beneficially owned.

Remarks:

The Reporting Person's title as an officer of the Issuer is Executive Vice President & General Counsel and President, Ophthalmic Pharmaceuticals. Exhibit 24 - Power of Attorney